PREOPERATIVE CHEMOTHERAPY VERSUS UPFRONT SURGERY FOR ADVANCED GASTRIC CANCER: A PROPENSITY SCORE MATCHING ANALYSIS

被引:6
作者
Hong, Stefany [1 ]
Pereira, Marina Alessandra [1 ]
Victor, Carolina Ribeiro [2 ]
Gregorio, Joao Vitor Antunes [2 ]
Zilberstein, Bruno [1 ]
Ribeiro Junior, Ulysses [1 ]
D'Albuquerque, Luiz Augusto Carneiro [1 ]
Ramos, Marcus Fernando Kodama Pertille [1 ]
机构
[1] Univ Sao Paulo, Hosp Clin, Fac Med, Dept Gastroenterol, Sao Paulo, SP, Brazil
[2] Univ Sao Paulo, Fac Med, Hosp Clin, Dept Radiol & Oncol, Sao Paulo, SP, Brazil
来源
ABCD-ARQUIVOS BRASILEIROS DE CIRURGIA DIGESTIVA-BRAZILIAN ARCHIVES OF DIGESTIVE SURGERY | 2023年 / 36卷 / 01期
关键词
Stomach neoplasms; Surgical procedures; operative; Propensity score; Neoadjuvant therapy; Drug therapy; combination; PERIOPERATIVE CHEMOTHERAPY; OPEN-LABEL; ADENOCARCINOMA; CAPECITABINE; OXALIPLATIN; MULTICENTER; REGRESSION; CARCINOMA; THERAPY; TRIAL;
D O I
10.1590/0102-672020230018e1736
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND: Surgical resection remains the main curative therapeutic modality for RESUMO -Racional: O tratamento de escolha para pacientes com hipertensao portal advanced gastric cancer. Recently, the association of preoperative chemotherapy has allowed the improvement of results without increasing surgical complications. AIMS: To evaluate the surgical esquistossomotica com sangramento de varizes e a desconexao azgo-portal mais and oncological outcomes of preoperative chemotherapy in a real-world setting. METHODS: A esplenectomia (DAPE) associada a trai doscopica. Porem, estudos ostrm aumento retrospective review of gastric cancer patients who underwent gastrectomy was performed. do calibre das varizes em alguns pacientes durante segimento em lngo prazo. Objetivo: Patients were divided into two groups for analysis: upfro nt surgery and preoperative chemotherapy. Avaliar o impacto da DAPE e tratamento endoscopico pos-operatorio no comportameno The propensity score matching analysis, including 9 variables, was applied to adjust for potential das varizes esofagicas e recidiva hemorragica, de pacientes esquistossomoticos. Metodos: confounding factors. RESULTS: Of the 536 patients included, 112 (20.9%) were referred for preoperative chemotherapy. Before the propensity score matching analysis, the groups were Foram estudados 36 pacientes com seguimento superior a cinco anos, distribuidos em different in terms of age, hemoglobin level, node metastasis at clinical stage-status, and extent dois grupos: queda da pressao portal abaixo de 30% e acima de 30% comparados com o of gastrectomy. After the analysis, 112 patients were stratified for each group. Both were similar calibre ds varize esofagicas no pos-operaorio precoce tardio ale do indice de reciiva for all variables assigned in the score. Patients in the preope rative chemotherapy group had less hemorragica. Resultados advanced postoperative p staging (p=0.010), postoperative n staging (p<0.001), and pTNM stage esofagicas que, durante o seguimento aumentaram de calibre e foram controladas com (p<0.001). Postoperative complications, 30-and 90-days mortality were similar between both groups. Before the propensity score matching analysis, there was no difference in survival between the groups. After the analysis, patients in the preoperative chemotherapy group had better overall o comportamento do calibre das varizes no pos-operatorio precoce nem tardio nm os survival compared to upfront surgery group (p=0.012). Multivariate analyses demonstrated that indices de recidiva hemorragica. Conclusao American Society of Anesthesiologists III/IV category and the presence of lymph node metastasis were factors significantly associated with worse overall survival. CONCLUSIONS: Preoperative operatorios precoces ou tardios. A comparacao entre a queda de pressao do portal e as chemotherapy was associated with increased survival in gastric cancer. There was no difference in the postoperative complication rate and mortality compared to upfront surgery.
引用
收藏
页数:8
相关论文
共 34 条
[1]   Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): Quality of combined modality therapy and pathologic response [J].
Ajani, Jaffer A. ;
Winter, Kathryn ;
Okawara, Gordon S. ;
Donohue, John H. ;
Pisters, Peter W. T. ;
Crane, Christopher H. ;
Greskovich, John F. ;
Anne, P. Rani ;
Bradley, Jeffrey D. ;
Willett, Christopher ;
Rich, Tyvin A. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (24) :3953-3958
[2]   Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial [J].
Al-Batran, Salah-Eddin ;
Homann, Nils ;
Pauligk, Claudia ;
Goetze, Thorsten O. ;
Meiler, Johannes ;
Kasper, Stefan ;
Kopp, Hans-Georg ;
Mayer, Frank ;
Haag, Georg Martin ;
Luley, Kim ;
Lindig, Udo ;
Schmiegel, Wolff ;
Pohl, Michael ;
Stoehlmacher, Jan ;
Folprecht, Gunnar ;
Probst, Stephan ;
Prasnikar, Nicole ;
Fischbach, Wolfgang ;
Mahlberg, Rolf ;
Trojan, Joerg ;
Koenigsmann, Michael ;
Martens, Uwe M. ;
Thuss-Patience, Peter ;
Egger, Matthias ;
Block, Andreas ;
Heinemann, Volker ;
Illerhaus, Gerald ;
Moehler, Markus ;
Schenk, Michael ;
Kullmann, Frank ;
Behringer, Dirk M. ;
Heike, Michael ;
Pink, Daniel ;
Teschendorf, Christian ;
Loehr, Carmen ;
Bernhard, Helga ;
Schuch, Gunter ;
Rethwisch, Volker ;
von Weikersthal, Ludwig Fischer ;
Hartmann, Joerg T. ;
Kneba, Michael ;
Daum, Severin ;
Schulmann, Karsten ;
Weniger, Joerg ;
Belle, Sebastian ;
Gaiser, Timo ;
Oduncu, Fuat S. ;
Guentner, Martina ;
Hozaeel, Wael ;
Reichart, Alexander .
LANCET, 2019, 393 (10184) :1948-1957
[3]   Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial [J].
Al-Batran, Salah-Eddin ;
Hofheinz, Ralf D. ;
Pauligk, Claudia ;
Kopp, Hans-Georg ;
Haag, Georg Martin ;
Luley, Kim Barbara ;
Meiler, Johannes ;
Homann, Nils ;
Lorenzen, Sylvie ;
Schmalenberg, Harald ;
Probst, Stephan ;
Koenigsmann, Michael ;
Egger, Matthias ;
Prasnikar, Nicole ;
Caca, Karel ;
Trojan, Joerg ;
Martens, Uwe M. ;
Block, Andreas ;
Fischbach, Wolfgang ;
Mahlberg, Rolf ;
Clemens, Michael ;
Illerhaus, Gerald ;
Zirlik, Katja ;
Behringer, Dirk M. ;
Schmiegel, Wolff ;
Pohl, Michael ;
Heike, Michael ;
Ronellenfitsch, Ulrich ;
Schuler, Martin ;
Bechstein, Wolf O. ;
Koenigsrainer, Alfred ;
Gaiser, Timo ;
Schirmacher, Peter ;
Hozaeel, Wael ;
Reichart, Alexander ;
Goetze, Thorsten O. ;
Sievert, Mark ;
Jaeger, Elke ;
Moenig, Stefan ;
Tannapfel, Andrea .
LANCET ONCOLOGY, 2016, 17 (12) :1697-1708
[4]   The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging [J].
Amin, Mahul B. ;
Greene, Frederick L. ;
Edge, Stephen B. ;
Compton, Carolyn C. ;
Gershenwald, Jeffrey E. ;
Brookland, Robert K. ;
Meyer, Laura ;
Gress, Donna M. ;
Byrd, David R. ;
Winchester, David P. .
CA-A CANCER JOURNAL FOR CLINICIANS, 2017, 67 (02) :93-99
[5]   A Comparison of Clinicopathologic Outcomes Across Neoadjuvant and Adjuvant Treatment Modalities in Resectable Gastric Cancer [J].
Anderson, Eric ;
LeVee, Alexis ;
Kim, Sungjin ;
Atkins, Katelyn ;
Guan, Michelle ;
Placencio-Hickok, Veronica ;
Moshayedi, Natalie ;
Hendifar, Andrew ;
Osipov, Arsen ;
Gangi, Alexandra ;
Burch, Miguel ;
Waters, Kevin ;
Cho, May ;
Klempner, Samuel ;
Chao, Joseph ;
Kamrava, Mitchell ;
Gong, Jun .
JAMA NETWORK OPEN, 2021, 4 (12)
[6]   Neoadjuvant Nivolumab Plus Ipilimumab and Adjuvant Nivolumab in Localized Deficient Mismatch Repair/Microsatellite Instability-High Gastric or Esophagogastric Junction Adenocarcinoma: The GERCOR NEONIPIGA Phase II Study [J].
Andre, Thierry ;
Tougeron, David ;
Piessen, Guillaume ;
de la Fouchardiere, Christelle ;
Louvet, Christophe ;
Adenis, Antoine ;
Jary, Marine ;
Tournigand, Christophe ;
Aparicio, Thomas ;
Desrame, Jerome ;
Lievre, Astrid ;
Garcia-Larnicol, Marie-Line ;
Pudlarz, Thomas ;
Cohen, Romain ;
Memmi, Salome ;
Vernerey, Dewi ;
Henriques, Julie ;
Lefevre, Jeremie H. ;
Svrcek, Magali .
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (02) :255-+
[7]   Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial [J].
Bang, Yung-Jue ;
Kim, Young-Woo ;
Yang, Han-Kwang ;
Chung, Hyun Cheol ;
Park, Young-Kyu ;
Lee, Kyung Hee ;
Lee, Keun-Wook ;
Kim, Yong Ho ;
Noh, Sang-Ik ;
Cho, Jae Yong ;
Mok, Young Jae ;
Kim, Yeul Hong ;
Ji, Jiafu ;
Yeh, Ta-Sen ;
Button, Peter ;
Sirzen, Florin ;
Noh, Sung Hoon .
LANCET, 2012, 379 (9813) :315-321
[8]   BRAZILIAN GASTRIC CANCER ASSOCIATION GUIDELINES (PART 2): UPDATE ON TREATMENT [J].
Barchi, Leandro Cardoso ;
Kodama Pertille Ramos, Marcus Fernando ;
Dias, Andre Roncon ;
Forones, Nora Manoukian ;
de Carvalho, Marineide Prudencio ;
Prado Castro, Osvaldo Antonio ;
Kassab, Paulo ;
da Costa-Junior, Wilson Luiz ;
Weston, Antonio Carlos ;
Zilberstein, Bruno .
ABCD-ARQUIVOS BRASILEIROS DE CIRURGIA DIGESTIVA-BRAZILIAN ARCHIVES OF DIGESTIVE SURGERY, 2021, 34 (01)
[9]   Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy [J].
Becker, K ;
Mueller, JD ;
Schulmacher, C ;
Ott, K ;
Fink, U ;
Busch, R ;
Böttcher, K ;
Siewert, JR ;
Höfler, H .
CANCER, 2003, 98 (07) :1521-1530
[10]   Comparisons of Gastric Cancer Treatments: East vs. West [J].
Bickenbach, Kai ;
Strong, Vivian E. .
JOURNAL OF GASTRIC CANCER, 2012, 12 (02) :55-62